The patent EP3664798A1 was granted to Amneal Pharmaceuticals on Jun 17, 2020 following the initial filing on Aug 6, 2018 under the application number EP18845286A . The current legal status of the patent is Intended To Grant.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents